167 related articles for article (PubMed ID: 18618506)
1. Significant antitumor activity of oncolytic adenovirus expressing human interferon-beta for hepatocellular carcinoma.
He LF; Gu JF; Tang WH; Fan JK; Wei N; Zou WG; Zhang YH; Zhao LL; Liu XY
J Gene Med; 2008 Sep; 10(9):983-92. PubMed ID: 18618506
[TBL] [Abstract][Full Text] [Related]
2. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
3. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
[TBL] [Abstract][Full Text] [Related]
4. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826
[TBL] [Abstract][Full Text] [Related]
5. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis.
Zheng JN; Pei DS; Sun FH; Liu XY; Mao LJ; Zhang BF; Wen RM; Xu W; Shi Z; Liu JJ; Li W
Cancer Biol Ther; 2009 Apr; 8(7):599-606. PubMed ID: 19305163
[TBL] [Abstract][Full Text] [Related]
6. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
Xu HN; Huang WD; Cai Y; Ding M; Gu JF; Wei N; Sun LY; Cao X; Li HG; Zhang KJ; Liu XR; Liu XY
Mol Cancer; 2011 Nov; 10():133. PubMed ID: 22040050
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis.
Zheng JN; Pei DS; Mao LJ; Liu XY; Sun FH; Zhang BF; Liu YQ; Liu JJ; Li W; Han D
Cancer Gene Ther; 2010 Jan; 17(1):28-36. PubMed ID: 19498459
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
[TBL] [Abstract][Full Text] [Related]
9. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
10. Potent antitumor efficacy of ST13 for colorectal cancer mediated by oncolytic adenovirus via mitochondrial apoptotic cell death.
Yang M; Cao X; Yu MC; Gu JF; Shen ZH; Ding M; Yu DB; Zheng S; Liu Xy
Hum Gene Ther; 2008 Apr; 19(4):343-53. PubMed ID: 18355116
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
12. A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas.
Kwon OJ; Kim PH; Huyn S; Wu L; Kim M; Yun CO
Clin Cancer Res; 2010 Dec; 16(24):6071-82. PubMed ID: 21169258
[TBL] [Abstract][Full Text] [Related]
13. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
14. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.
Zhang ZL; Zou WG; Luo CX; Li BH; Wang JH; Sun LY; Qian QJ; Liu XY
Cell Res; 2003 Dec; 13(6):481-9. PubMed ID: 14728805
[TBL] [Abstract][Full Text] [Related]
15. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
17. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.
Liu J; Fang L; Cheng Q; Li L; Su C; Zhang B; Pei D; Yang J; Li W; Zheng J
Cancer Sci; 2012 Oct; 103(10):1880-8. PubMed ID: 22775978
[TBL] [Abstract][Full Text] [Related]
18. Potent antitumor activity of oncolytic adenovirus expressing C/EBPβ against hepatocellular carcinoma.
Zeng Y; Li FD; Du JL; Xue YJ; Liu J; Cao X; Wang HZ
Apoptosis; 2020 Apr; 25(3-4):154-156. PubMed ID: 32026186
[No Abstract] [Full Text] [Related]
19. Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.
Su CQ; Wang XH; Chen J; Liu YJ; Wang WG; Li LF; Wu MC; Qian QJ
World J Gastroenterol; 2006 Dec; 12(47):7613-20. PubMed ID: 17171789
[TBL] [Abstract][Full Text] [Related]
20. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]